(2S,4R)-1-[(2S)-2-[7-[[6-cyclopropyl-4-[(1S,4S)-2,5-diazabicyclo[2.2.1]heptan-2-yl]-7-(6-fluoro-5-methyl-1H-indazol-4-yl)-2-(oxan-4-yloxy)quinazolin-8-yl]oxymethyl]-4-oxo-5H-pyrazolo[3,4-c]quinolin-2-yl]-3-methylbutanoyl]-N-[[5-(2-ethylpyrazol-3-yl)-1,2,3,4-tetrahydroisoquinolin-8-yl]methyl]-4-hydroxypyrrolidine-2-carboxamide
C65H71FN14O7 — CID 176976105
Data last refreshed: (MolForge compound catalog, from PubChem)
About (2S,4R)-1-[(2S)-2-[7-[[6-cyclopropyl-4-[(1S,4S)-2,5-diazabicyclo[2.2.1]heptan-2-yl]-7-(6-fluoro-5-methyl-1H-indazol-4-yl)-2-(oxan-4-yloxy)quinazolin-8-yl]oxymethyl]-4-oxo-5H-pyrazolo[3,4-c]quinolin-2-yl]-3-methylbutanoyl]-N-[[5-(2-ethylpyrazol-3-yl)-1,2,3,4-tetrahydroisoquinolin-8-yl]methyl]-4-hydroxypyrrolidine-2-carboxamide
(2S,4R)-1-[(2S)-2-[7-[[6-cyclopropyl-4-[(1S,4S)-2,5-diazabicyclo[2.2.1]heptan-2-yl]-7-(6-fluoro-5-methyl-1H-indazol-4-yl)-2-(oxan-4-yloxy)quinazolin-8-yl]oxymethyl]-4-oxo-5H-pyrazolo[3,4-c]quinolin-2-yl]-3-methylbutanoyl]-N-[[5-(2-ethylpyrazol-3-yl)-1,2,3,4-tetrahydroisoquinolin-8-yl]methyl]-4-hydroxypyrrolidine-2-carboxamide (PubChem CID 176976105) has the molecular formula C65H71FN14O7 and a molecular weight of 1179.37 g/mol. Its IUPAC name is (2S,4R)-1-[(2S)-2-[7-[[6-cyclopropyl-4-[(1S,4S)-2,5-diazabicyclo[2.2.1]heptan-2-yl]-7-(6-fluoro-5-methyl-1H-indazol-4-yl)-2-(oxan-4-yloxy)quinazolin-8-yl]oxymethyl]-4-oxo-5H-pyrazolo[3,4-c]quinolin-2-yl]-3-methylbutanoyl]-N-[[5-(2-ethylpyrazol-3-yl)-1,2,3,4-tetrahydroisoquinolin-8-yl]methyl]-4-hydroxypyrrolidine-2-carboxamide.
Molecular Properties
| Compound Name | (2S,4R)-1-[(2S)-2-[7-[[6-cyclopropyl-4-[(1S,4S)-2,5-diazabicyclo[2.2.1]heptan-2-yl]-7-(6-fluoro-5-methyl-1H-indazol-4-yl)-2-(oxan-4-yloxy)quinazolin-8-yl]oxymethyl]-4-oxo-5H-pyrazolo[3,4-c]quinolin-2-yl]-3-methylbutanoyl]-N-[[5-(2-ethylpyrazol-3-yl)-1,2,3,4-tetrahydroisoquinolin-8-yl]methyl]-4-hydroxypyrrolidine-2-carboxamide |
|---|---|
| PubChem CID | 176976105 |
| Molecular Formula | C65H71FN14O7 |
| Molecular Weight | 1179.37 g/mol |
| Exact Mass | 1178.56 |
| IUPAC Name | (2S,4R)-1-[(2S)-2-[7-[[6-cyclopropyl-4-[(1S,4S)-2,5-diazabicyclo[2.2.1]heptan-2-yl]-7-(6-fluoro-5-methyl-1H-indazol-4-yl)-2-(oxan-4-yloxy)quinazolin-8-yl]oxymethyl]-4-oxo-5H-pyrazolo[3,4-c]quinolin-2-yl]-3-methylbutanoyl]-N-[[5-(2-ethylpyrazol-3-yl)-1,2,3,4-tetrahydroisoquinolin-8-yl]methyl]-4-hydroxypyrrolidine-2-carboxamide |
| SMILES | CCn1nccc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@H](C(C)C)n2cc3c(n2)c(=O)[nH]c2cc(COc4c(-c5c(C)c(F)cc6[nH]ncc56)c(C5CC5)cc5c(N6C[C@@H]7C[C@H]6CN7)nc(OC6CCOCC6)nc45)ccc23)c2c1CCNC2 |
| InChI | InChI=1S/C65H71FN14O7/c1-5-79-53(13-17-71-79)44-11-9-37(47-27-67-16-12-42(44)47)25-69-62(82)54-22-40(81)30-78(54)64(84)59(33(2)3)80-31-49-43-10-6-35(20-51(43)72-63(83)58(49)76-80)32-86-60-56(55-34(4)50(66)24-52-48(55)28-70-75-52)45(36-7-8-36)23-46-57(60)73-65(87-41-14-18-85-19-15-41)74-61(46)77-29-38-21-39(77)26-68-38/h6,9-11,13,17,20,23-24,28,31,33,36,38-41,54,59,67-68,81H,5,7-8,12,14-16,18-19,21-22,25-27,29-30,32H2,1-4H3,(H,69,82)(H,70,75)(H,72,83)/t38-,39-,40+,54-,59-/m0/s1 |
| InChIKey | QIWRSPBUFONDCK-DHRXQNFFSA-N |
| XLogP | 7.38 |
| TPSA | 247.59 Ų |
| H-Bond Donors | 6 |
| H-Bond Acceptors | 17 |
| Rotatable Bonds | 16 |
| Heavy Atoms | 87 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1179.37 |
| LogP ≤ 5 | 7.38 |
| H-Bond Donors ≤ 5 | 6 |
| H-Bond Acceptors ≤ 10 | 17 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 176976105 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.